Select Page

Fw: [asid-ozbug] pre-operative disinfectants

Home Forums Infexion Connexion Fw: [asid-ozbug] pre-operative disinfectants

 | Click to Receive Email Notifications of Posts
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #68324
    Matthias.Maiwald@KKH.COM.SG Subject: Fw: [asid-ozbug] pre-operative disinfectants MIME-Version: 1.0 Content-type: text/plain; charset=US-ASCII Message-ID:
    Participant

    Author:
    Matthias.Maiwald@KKH.COM.SG Subject: Fw: [asid-ozbug] pre-operative disinfectants MIME-Version: 1.0 Content-type: text/plain; charset=US-ASCII Message-ID:

    Position:

    Organisation:

    State:

    Dear Group,

    Just cross-posting my comments from OzBug. (Sequence of comments from
    bottom to top). This issue was also discussed in a similar way on AICA
    List.

    Best regards, Matthias.


    Matthias Maiwald, MD, FRCPA, D(ABMM)
    Consultant in Microbiology
    Department of Pathology and Laboratory Medicine
    KK Women’s and Children’s Hospital
    100 Bukit Timah Road
    Singapore 229899
    Tel. +65 6394 1389
    Fax +65 6394 1387

    —– Forwarded by Matthias MAIWALD/LAB/KKH on 29/06/2010 08:28 AM —–

    Matthias.Maiwald@
    kkh.com.sg
    Sent by: To
    asid-ozbug-bounce “Ingram, Paul”
    s@malbec.burnet.e
    du.au cc
    asid-ozbug@burnet.edu.au,
    asid-ozbug-bounces@malbec.burnet.ed
    17/06/2010 10:27 u.au
    AM Subject
    Re: [asid-ozbug] pre-operative
    disinfectants

    Dear Paul,

    I have dealt with this question extensively during my time in Adelaide (at
    Flinders) and subsequently. I have also made a submission to the NHMRC
    guideline committee while the draft was out for public comment, and I have
    given a number of talks to surgical and infection control audiences on the
    issue of surgical (and general) skin antisepsis (‘skin prep’). I am happy
    to send some of the overview materials that I have prepared, but it might
    be better outside OzBug, because sending uninvited attachments to OzBug may
    not be the best thing.

    A few key issues:

    The agents in question (alcohols, chlorhexidine, povidone-iodine) have been
    studied extensively since the 1970s. It is clear that alcohols have
    significantly greater antimicrobial activity against microorganisms on skin
    than the other two agents when they are used in aqueous solution. The
    difference is typically about 1 log (i.e. a tenfold difference) in favour
    of the alcohols. Alcohols have the greatest immediate antimicrobial killing
    effect, while they have no residual activity. The other two agents have
    significantly inferior immediate effect, but they appear to have persistent
    action (chlorhexidine does, the one of PVP-I is questionable). Because it
    is an advantage to have persistent action on skin and under the surgical
    drapes for the time of surgery, it is an advantage to use a mix of alcohols
    plus one of the two other agents (e.g. 70% isopropanol plus 2%
    chlorhexidine), in order to provide immediate kill plus persistence for the
    time of the operation.

    A table with a spectrum of activity and immediate vs. persistent activity
    of skin antiseptics has been published in the CDC guideline on prevention
    of surgical site infections (Mangram et al. 1999) as well as in the WHO
    hand hygiene guideline (2009).

    It is also clear that alcohols are only suitable for superficial skin and
    unsuitable to be used on mucous membranes (e.g. oral, ENT, eye, vaginal
    surgery), so that aqueous agents have to be used for mucous membranes.

    Several countries in central Europe have been using alcohol-based surgical
    skin antiseptics for decades, and because of the well-known significant
    difference in antimicrobial kill (see above), ethics committees in those
    settings in Europe would not have approved a study such as the NEJM one
    (Darouiche et al. 2010).

    In addition to the Darouiche 2010 NEJM study, there are several other
    clinical studies (with SSI rates as outcome) that document quite clearly
    that either alcohol-based preps or intensified skin prep regimens (vs. less
    intensive ones) make a clear positive impact on SSI rates, thus confirming
    the validity of the microbiological studies.

    It is clear from a synopsis of the literature that skin is the most
    significant causative source of SSIs in clean surgery (this includes
    orthopaedic surgery), whereas in contaminated surgery, the causation shifts
    and other sources assume (in relative terms) a greater role.

    We have also assessed the issue of fire risk from flammable skin preps
    (Maiwald M et al. Letter to the Editor. ANZ J Surg 76: 422-3; 2006), with
    the following conclusions: (1) fires from flammable skin preps are
    extremely rare, (2) all cases for which there is background information
    available have been caused by inadvertent misuse, e.g. pouring the
    antiseptic over the patient, not waiting for the skin to dry, causing
    pooling or wetting of drapes, using diathermy on alcohol-wet patients,
    etc.), and (3) weighing the risk of surgical fires against the risk of
    surgical site infections (SSIs), it becomes clear that even a minimal
    reduction in SSI rates outweighs the (well preventable) risk of surgical
    fires by several orders of magnitude.

    There are two other things that appear to be important on microbiological
    grounds and based on anecdotal and empirical findings. These are: (1) that
    repeated application of the skin antiseptic with some mild friction and (2)
    a sufficient contact time of the antiseptic on skin appear to be important.
    Concerning (1), there are no published guidelines, but most experts in skin
    antisepsis that I have talked to recommend 3 repeated applications, and
    concerning (2), the Royal College of Surgeons of Australasia in their
    infection control guideline recommends “at least 2 but preferably 5
    minutes” of contact time before commencing surgery. (I am not sure how many
    Australian surgeons are aware of their own College’s contact time
    recommendation).

    In Adelaide, several surgical units have successfully implemented the
    change from aqueous to alcoholic skin preps (for superficial skin) without
    any problems, but since I have moved away from Adelaide, I have not been
    able to follow up on further details.

    Since there are some issues to be aware of (see above), it appears that
    education and information of surgeons is important. While in Adelaide, I
    have given a number of talks to surgical units (e.g. proper usage,
    avoidance of fire risk, etc.).

    Best regards, Matthias.


    Matthias Maiwald, MD, FRCPA, D(ABMM)
    Consultant in Microbiology
    Department of Pathology and Laboratory Medicine
    KK Women’s and Children’s Hospital
    100 Bukit Timah Road
    Singapore 229899
    Tel. +65 6394 1389
    Fax +65 6394 1387

    “Ingram, Paul”
    To
    Sent by:
    asid-ozbug-bounce cc
    s@malbec.burnet.e
    du.au Subject
    [asid-ozbug] pre-operative
    disinfectants
    17/06/2010 09:09
    AM

    Dear Ozbuggers,

    Earlier this year NEJM published an RCT comparing 2% chlorhexidine-alcohol
    vs povidine-idoine for prevention of surgical site infection demonstrating
    superiority of chlorhex-alchohol, as evident by a 41% reduction in the ITT
    analysis (N Engl J Med 2010;362:18-26).

    Currently both the Australian Guidelines For The Prevention and Control of
    Infection in Healthcare Consultation 2010 draft and the 2008 SHEA-IDSA
    guidelines on prevention of SSI suggest either chlorhex or iodine based
    pre-op disinfectants. Whether this should still be the case is presumably
    now in doubt.
    We are considering changing our hospital policy in keeping with the study
    findings. The cost of 100mL of 2% chlorhex-alcohol and povidine-iodine from
    our local supplier is almost equivalent ($3-4/100mL).
    Are others considering changing their local pre-operative disinfectant
    practices/policy? If so, what have their experiences been? Perceived
    barriers would be the inherent inertia within surgeon practices, concerns
    about the ability to extrapolate beyond the study population
    (clean-contaminated surgery- ie elective entry into respiratory, biliary,
    gastrointestinal, urinary tracts and with minimal spillage. This does not
    include elective orthopedic surgery, nor contaminated emergency surgery),
    worries about toxicity (eg keratitis with chlorhex) and flammability of
    alcohol. The performance of alcohol (vs aqueous) based iodine solutions is
    also not clear, as this was not included in the RCT.
    Paul Ingram
    Microbiology/Infectious Diseases Registrar,
    Sir Charles Gairdner Hospital, Perth.

    —————————————————————————–
    The information contained in this e-mail or in any attachment is
    confidential and may be privileged. If you are not the intended recipient,
    you are not authorised to read, print, retain, copy, disseminate,
    distribute, or use this e-mail or any part thereof. If you receive this
    e-mail in error, please notify the sender immediately by e-mail and delete
    all copies of this e-mail. All opinions, conclusions and other information
    expressed in this e-mail that are not of an official nature shall not be
    deemed as given or endorsed by KK Women’s & Children’s Hospital.

    Insofar as this e-mail contains any medical opinion or advice, the medical
    opinion or advice is premised solely on the extent of medical information
    available to the writer of this e-mail and, where applicable, qualified by
    the lack of direct physical assessment and personal evaluation of the
    patient. Any medical opinion or advice expressed in this email does not
    necessarily represent the views of KK Women’s & Children’s Hospital.

    Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of AICA.
    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

Viewing 1 post (of 1 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.